Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Galapagos initiates first-in-human trial of GLPG-3121

April 11, 2019

Aduro BioTech discovers cyclic GMP-AMP synthase inhibitors

April 9, 2019

New IL-10 production enhancers patented by Daiichi Sankyo

April 8, 2019

G protein-coupled receptor 35 agonists described by Okayama University and Kogakuin University

April 8, 2019

NLRP3 antagonist IFM-2427 enters first-in-human trial

March 29, 2019

Lysophosphatidic acid receptor 1 antagonists identified at Lilly

March 27, 2019

Unusual anti-inflammatory meroterpenoids isolated from the marine sponge Dysidea septosa

March 22, 2019

XW Laboratories identifies ROS production inhibitors

March 22, 2019

Coming up for air

March 21, 2019

BioTheryX patents IL-1beta, IL-6, IL-2 and TNF-alpha production inhibitors

March 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...